Randomization, permuted blocks, masking, allocation concealment, and selection bias in the Tobacco Quit Line Study

Contemporary Clinical Trials

Volumn 31, Issue 3, 2010, Pages 201-

  Berger, Vance W ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

Author keywords

Allocation concealment; Clinical trial; Masking; Permuted blocks; Restricted randomization; Selection bias

Indexed keywords

CLINICAL STUDY; CLINICAL TRIAL; EPIDEMIOLOGY; LETTER; MASKING; MEDICAL RESEARCH; METHODOLOGY; RANDOMIZATION; TOBACCO QUIT LINE STUDY;

DOUBLE-BLIND METHOD; HUMANS; RANDOM ALLOCATION; RESEARCH DESIGN; SELECTION BIAS; SINGLE-BLIND METHOD; SMOKING CESSATION;

EID: 77950917111     PISSN: 15517144     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cct.2010.02.004     Document Type: Letter

References (6)

1. Asfar T., Klesges R.C., Sanford S.D., et al. Trial design: The St. Jude Children's Research Hospital Cancer Survivors Tobacco Quit Line Study. Contemp Clin Trials 31 (2010) 82-91
2. Berger V.W., and Alperson S.Y. A general framework for the evaluation of clinical trial quality. Rev Recent Clin Trials 4 2 (2009) 79-88
3. Berger V.W. Selection bias and covariate imbalances in randomized clinical trials (2005), John Wiley & Sons, Chichester
4. Berger V.W., Ivanova A., and Deloria-Knoll M. Minimizing predictability while retaining balance through the use of less restrictive randomization procedures. Stat Med 22 19 (2003) 3017-3028
5. Berger V.W. Quantifying the magnitude of baseline covariate imbalances resulting from selection bias in randomized clinical trials (with discussion). Biom J 47 2 (2005) 119-127
6. Berger V.W., and Exner D.V. Detecting selection bias in randomized clinical trials. Control Clin Trials 20 (1999) 319-327